When members of the marine mammal team from the International Fund for Animal Welfare rush to a Cape Cod beach to help a stranded dolphin or porpoise, they have no choice but to treat the endangered animal on site and then immediately release it.
That is about to change.
The organization, which protects animals worldwide, is opening a first-of-its-kind short-term dolphin hospital on Cape Cod this month that it hopes will not only improve survivability rates, but also enhance the research it has developed over 25 years.
Stranded marine mammals are stressed, in shock and dehydrated, said Brian Sharp, director of the rescue team. Simply caring for them at the scene is often not enough. They need additional diagnostics, treatment and recovery time.
“With this ICU for dolphins, we’ll be able to get them treatment that's needed, then be able to release them quickly,” he said.
While there are marine mammal rehabilitation centers that can take care of animals for months or even years, the goal of this facility is to release them back into the ocean within four days, he said.
“This is the first time that this has been attempted before," Sharp said.
There are more live marine mammal strandings on Cape Cod than anywhere else in the world, Sharp said. The welfare fund has responded to more than 400 live stranded dolphins, whales and porpoises in the region in the past five years alone, the organization said in a news release.
Cape Cod is a good habitat for dolphins, but a risky one. Its geography — it is basically a hook-shaped spit of sand jutting into the ocean — can make dolphin navigation difficult, and 12-foot tides can quickly expose a mile of beach.
The 4,200-square-foot (390-square-meter) Dolphin Rescue Center is in a renovated retail space in downtown Orleans.
It includes an 1,800-square-foot (167-square-meter) rehabilitation area with two treatment pools 15 feet (4.3 meters) across and a veterinary laboratory. The public will not be permitted to have direct contact with the animals being a cared for, but there is also an education center where visitors will be able to watch the recovering animals on a monitor.
Staffed by four full-time workers, it is equipped to provide round-the-clock care. It will start by treating one animal at a time, but the goal is to eventually treat multiple animals simultaneously.
The privately funded center has been federally inspected and expects to open by the end of the month, Sharp said.
“We want to take what we learn here and share it nationally, internationally,” he said.
A subvariant of the omicron COVID-19 variant called BA.2 is causing an outbreak overseas. Now, some health experts worry it could also lead to an increase in COVID-19 cases in the U.S. Dr. Amesh Adalja, infectious disease specialist and senior scholar at Johns Hopkins Center for Health Security, joins Cheddar News to discuss.
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
Tyler Hayes, CEO of Atom Limbs, joins Cheddar Innovates to discuss how the Atom Touch prosthetic is different from other prosthetics on the market, and how the Atom Limbs team of former Apple and Tesla leaders are bringing innovation into this industry.
Nouveau Monde Graphite says it wants to power the sustainable energy revolution. The Canadian company is developing carbon-neutral battery materials to serve the growing EV and cleantech markets and is doing so via a mining and manufacturing operation in Quebec. Eric Desaulniers, founder, president & CEO of Nouveau Monde Graphite, joins Cheddar News' Closing Bell to discuss.
Health experts are warning an even more contagious subvariant of Omicron, known as BA.2, could soon lead to another surge in Covid cases here in the U.S. The variant has already driven cases to skyrocket in China and Europe, which has historically served as a preview to the pattern the U.S. has seen throughout the pandemic. This comes at a time when protection from booster shots is waning for most people who got them. Dr. Jen Caudle, Family Physician & Associate Professor at Rowan University, explains what we can do to protect ourselves against the new variant and how we should act as warnings of another surge rise.
Catching you up on what you need to know Mar 24, 2022, with NATO meeting updates, Ukraine retaking suburbs around Kyiv, the spread of omicron subvariant BA.2 in China, Google Pay launching a third-party billing option, and a 16-year-old is suspected of being the Lapsus$ mastermind behind hacks of Microsoft and others.
Cannabis producer Cresco Labs is acquiring rival Columbia Care in a $2 billion all-stock deal, creating the largest U.S. cannabis company by sales. The deal, which is expected to close in the fourth quarter of 2022, is one of the biggest in the industry's history and would make Cresco the dominant player in a market projected to reach $46 billion in revenue by 2026. Charlie Bachtell, CEO of Cresco Labs, joins Cheddar News' Closing Bell to discuss.
Moderna announced it's seeking emergency use approval for its COVID-19 vaccine from the FDA for children under 6 years old. A former FDA associate commissioner and the president and co-founder of the Center for Medicine in the Public Interest (CMPI) Peter Pitts joined Cheddar News to talk about the timeline, benefits, and risks that come with the approval of the vaccine. "We want to protect their parents and their grandparents and their caregivers and their daycare providers, so it's all about protecting not just the kids but all around the people that are surrounding those kids," he said.
Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers. The company announced early findings Wednesday from a study of children younger than 6.
Catching you up on what you Need to Know on Mar 23, 2022, as NATO meets in Brussels to discuss Ukraine, mortgage rates rise, Justin Trudeau is set to lead Canada until 2025, tornadoes sweep through Louisiana, California may do away with SATs, and a Starbucks in Seattle unionizes.
